Literature DB >> 4975543

Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis.

J M Dickinson, G A Ellard, D A Mitchison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4975543     DOI: 10.1016/s0041-3879(68)80016-9

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  21 in total

Review 1.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

2.  Intermittent treatment regimens in pulmonary tuberculosis.

Authors:  M Zierski
Journal:  Lung       Date:  1979       Impact factor: 2.584

Review 3.  General considerations in intermittent drug therapy of pulmonary tuberculosis.

Authors:  W Fox
Journal:  Postgrad Med J       Date:  1971-11       Impact factor: 2.401

4.  Laboratory aspects of intermittent drug therapy.

Authors:  D A Mitchison; J M Dickinson
Journal:  Postgrad Med J       Date:  1971-11       Impact factor: 2.401

Review 5.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

6.  Tuberculous infection.

Authors:  D A Mitchison
Journal:  Proc R Soc Med       Date:  1971-05

7.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

8.  [New paths of chemotherapy].

Authors:  G Urbanczik
Journal:  Pneumonologie       Date:  1971

9.  A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis.

Authors: 
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

Review 10.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.